Chen, T.; Chen, H.; Jiang, Y.; Yan, Q.; Zheng, S.; Wu, M.
Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment. Pharmaceuticals 2022, 15, 881.
https://doi.org/10.3390/ph15070881
AMA Style
Chen T, Chen H, Jiang Y, Yan Q, Zheng S, Wu M.
Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment. Pharmaceuticals. 2022; 15(7):881.
https://doi.org/10.3390/ph15070881
Chicago/Turabian Style
Chen, Tianyu, Hui Chen, Yichun Jiang, Qi Yan, Shuling Zheng, and Min Wu.
2022. "Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment" Pharmaceuticals 15, no. 7: 881.
https://doi.org/10.3390/ph15070881
APA Style
Chen, T., Chen, H., Jiang, Y., Yan, Q., Zheng, S., & Wu, M.
(2022). Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment. Pharmaceuticals, 15(7), 881.
https://doi.org/10.3390/ph15070881